NEW YORK, Aug. 7, 2015 /PRNewswire/ -- Securities lawyers at Dunnam & Dunnam are investigating the board of Merge Healthcare (NASDAQ: MRGE) in connection with a buyout for only $7.13 per share. Concerned MRGE investors are encouraged to contact attorney Hamilton Lindley by clicking here.
The investigation focuses upon the shareholder value of the transaction. The investigation concerns whether Merge's board of directors failed to adequately shop the Company and obtain the best possible value for Merge's shareholders before entering into an agreement with IBM. On August 6, 2015, the two companies announced the signing of a definitive merger agreement pursuant to which IBM will acquire Merge. "Our potential shareholder lawsuit will seek to ensure Merge Healthcare shareholders receive the highest price reasonably available for their stock and that all relevant information is disclosed."
Dunnam & Dunnam has significant experience representing shareholders in securities lawsuits nationwide. MRGE stockholders – or anyone with knowledge about this situation – should contact lawyer Hamilton Lindley at firstname.lastname@example.org with questions, toll free at (844) 702-2990 or visit http://www.dunnamlaw.com/MRGE.
SOURCE Dunnam & Dunnam LLP